313 related articles for article (PubMed ID: 27225513)
1. Comprehensive review on cardio-oncology: Role of multimodality imaging.
Chen-Scarabelli C; McRee C; Leesar MA; Hage FG; Scarabelli TM
J Nucl Cardiol; 2017 Jun; 24(3):906-935. PubMed ID: 27225513
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive diagnostic approach to cardiac events in cancer patients receiving antineoplastic therapy: A systematic review.
Lafaras C; Kalafatis I; Lafara K; Koukoulitsa V; Mandala E
Hell J Nucl Med; 2023; 26 Suppl():5-11. PubMed ID: 37658551
[TBL] [Abstract][Full Text] [Related]
3. The role and clinical effectiveness of multimodality imaging in the management of cardiac complications of cancer and cancer therapy.
Russell RR; Alexander J; Jain D; Poornima IG; Srivastava AV; Storozynsky E; Schwartz RG
J Nucl Cardiol; 2016 Aug; 23(4):856-84. PubMed ID: 27251147
[TBL] [Abstract][Full Text] [Related]
4. Emergence of cardio-oncology.
Nebigil CG; Désaubry L
Ann Pharm Fr; 2018 Nov; 76(6):504-506. PubMed ID: 30075937
[TBL] [Abstract][Full Text] [Related]
5. Cardiac Imaging in Oncology Patients in Europe: a Model for Advancement of CV Safety and Development of Comprehensive CV Care.
López-Fernández T
J Cardiovasc Transl Res; 2020 Jun; 13(3):490-494. PubMed ID: 32583314
[TBL] [Abstract][Full Text] [Related]
6. Multimodality Cardiac Imaging in the Era of Emerging Cancer Therapies.
Biersmith MA; Tong MS; Guha A; Simonetti OP; Addison D
J Am Heart Assoc; 2020 Jan; 9(2):e013755. PubMed ID: 31960741
[No Abstract] [Full Text] [Related]
7. Optimizing cardio-oncology programs for cancer patients.
Francis SA; Asnani A; Neilan T; Scherrer-Crosbie M
Future Oncol; 2015; 11(14):2011-5. PubMed ID: 26198828
[No Abstract] [Full Text] [Related]
8. Nuclear cardio-oncology: From its foundation to its future.
Kahanda MG; Hanson CA; Patterson B; Bourque JM
J Nucl Cardiol; 2020 Apr; 27(2):511-518. PubMed ID: 30788760
[TBL] [Abstract][Full Text] [Related]
9. Cardio-Oncology: Progress in Diagnosis and Treatment of Cardiac Dysfunction.
Tromp J; Steggink LC; Van Veldhuisen DJ; Gietema JA; van der Meer P
Clin Pharmacol Ther; 2017 Apr; 101(4):481-490. PubMed ID: 28073142
[No Abstract] [Full Text] [Related]
10. Cardiotoxic effects of chemotherapy: A review of both cytotoxic and molecular targeted oncology therapies and their effect on the cardiovascular system.
Babiker HM; McBride A; Newton M; Boehmer LM; Drucker AG; Gowan M; Cassagnol M; Camenisch TD; Anwer F; Hollands JM
Crit Rev Oncol Hematol; 2018 Jun; 126():186-200. PubMed ID: 29759560
[TBL] [Abstract][Full Text] [Related]
11. Advances in Multimodality Imaging in Cardio-Oncology: JACC State-of-the-Art Review.
Baldassarre LA; Ganatra S; Lopez-Mattei J; Yang EH; Zaha VG; Wong TC; Ayoub C; DeCara JM; Dent S; Deswal A; Ghosh AK; Henry M; Khemka A; Leja M; Rudski L; Villarraga HR; Liu JE; Barac A; Scherrer-Crosbie M;
J Am Coll Cardiol; 2022 Oct; 80(16):1560-1578. PubMed ID: 36229093
[TBL] [Abstract][Full Text] [Related]
12. Update on cardio-oncology: Novel cancer therapeutics and associated cardiotoxicities.
Guha A; Armanious M; Fradley MG
Trends Cardiovasc Med; 2019 Jan; 29(1):29-39. PubMed ID: 29910109
[TBL] [Abstract][Full Text] [Related]
13. Echocardiography and Cardio-Oncology.
Negishi T; Miyazaki S; Negishi K
Heart Lung Circ; 2019 Sep; 28(9):1331-1338. PubMed ID: 31230869
[TBL] [Abstract][Full Text] [Related]
14. Metabolic Imaging in Cardio-oncology.
Tong D; Zaha VG
J Cardiovasc Transl Res; 2020 Jun; 13(3):357-366. PubMed ID: 31696405
[TBL] [Abstract][Full Text] [Related]
15. Nuclear cardiology in the context of multimodality imaging to detect cardiac toxicity from cancer therapeutics: Established and emerging methods.
Soufer A; Liu C; Henry ML; Baldassarre LA
J Nucl Cardiol; 2020 Aug; 27(4):1210-1224. PubMed ID: 30868378
[TBL] [Abstract][Full Text] [Related]
16. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).
Zamorano JL; Lancellotti P; Rodriguez Muñoz D; Aboyans V; Asteggiano R; Galderisi M; Habib G; Lenihan DJ; Lip GY; Lyon AR; Lopez Fernandez T; Mohty D; Piepoli MF; Tamargo J; Torbicki A; Suter TM; Zamorano JL; Aboyans V; Achenbach S; Agewall S; Badimon L; Barón-Esquivias G; Baumgartner H; Bax JJ; Bueno H; Carerj S; Dean V; Erol Ç; Fitzsimons D; Gaemperli O; Kirchhof P; Kolh P; Lancellotti P; Lip GY; Nihoyannopoulos P; Piepoli MF; Ponikowski P; Roffi M; Torbicki A; Vaz Carneiro A; Windecker S; ; ;
Eur J Heart Fail; 2017 Jan; 19(1):9-42. PubMed ID: 27565769
[No Abstract] [Full Text] [Related]
17. [Treatment recommendations in cardio-oncology: where are we?].
Müller OJ; Baldus CD
Internist (Berl); 2020 Nov; 61(11):1125-1131. PubMed ID: 33025122
[TBL] [Abstract][Full Text] [Related]
18. Cardio-oncology - strategies for management of cancer-therapy related cardiovascular disease.
Totzeck M; Schuler M; Stuschke M; Heusch G; Rassaf T
Int J Cardiol; 2019 Apr; 280():163-175. PubMed ID: 30661849
[TBL] [Abstract][Full Text] [Related]
19. Introduction to the Cardio-Oncology Miniseries.
Davidoff R; Fifer M; Francis S
Circulation; 2015 Nov; 132(19):1834. PubMed ID: 26553712
[No Abstract] [Full Text] [Related]
20. Personalized medicine in cardio-oncology: the role of induced pluripotent stem cell.
Sayed N; Ameen M; Wu JC
Cardiovasc Res; 2019 Apr; 115(5):949-959. PubMed ID: 30768178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
